Estrogen and androgen receptor status in hepatocellular hypertrophy induced by phenobarbital, clofibrate, and piperonyl butoxide in F344 rats

Journal of Toxicological Sciences

Volumn 37, Issue 2, 2012, Pages 281-286

  Fujimoto, Nariaki ^a   Inoue, Kaoru ^b   Yoshida, Midori ^b   Nishikawa, Akiyoshi ^b   Ozawa, Shogo ^c   Gamou, Toshie ^c   Nemoto, Kiyomitsu ^d   Degawa, Masakuni ^d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Chlofibrate; Estrogen receptor; Hepatic hypertrophy; LIFR; Phenobarbital; Piperonyl butoxide (PBO)

Indexed keywords

ANDROGEN RECEPTOR; CLOFIBRATE; ESTROGEN RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MESSENGER RNA; PHENOBARBITAL; PIPERONYL BUTOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; GENE EXPRESSION; LIVER CELL CARCINOMA; LIVER HYPERTROPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

RATTUS;

EID: 84859299842     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.281     Document Type: Article

References (30)

1. Boix, L., Bruix, J., Castells, A., Fuster, J., Bru, C., Visa, J., Rivera, F. and Rodes, J. (1993): Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment? J. Hepatol., 17, 187-191.
2. Carter, N.D., Shiels, A., Jeffery, S., Heath, R., Wilson, C.A., Phillips, I.R. and Shephard, E.A. (1984): Hormonal control of carbonic anhydrase III. Ann. N. Y. Acad. Sci., 429, 287-301.
3. Chatterjee, B. and Roy, A.K. (1990): Changes in hepatic androgen sensitivity and gene expression during aging. J. Steroid Biochem. Mol. Biol., 37, 437-445.
4. de la Iglesia, N., Konopka, G., Puram, S.V., Chan, J.A., Bachoo, R.M., You, M.J., Levy, D.E., Depinho, R.A. and Bonni, A. (2008): Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev., 22, 449-462.
5. Diel, P., Walter, A., Fritzemeier, K.H., Hegele-Hartung, C. and Knauthe, R. (1995):Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. J. Steroid Biochem. Mol. Biol., 55, 363-373.
6. Dragan, Y.P., Xu, Y.D. and Pitot, H.C. (1991): Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Prev. Med., 20, 15-26.
7. Eagon, P.K., Elm, M.S., Epley, M.J., Shinozuka, H. and Rao, K.N. (1996): Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology, 110, 1199-1207.
8. Farinati, F., Cardin, R., Bortolami, M., Grottola, A., Manno, M., Colantoni, A. and Villa, E. (2002): Estrogens receptors and oxidative damage in the liver. Mol. Cell Endocrinol., 193, 85-88.
9. Francavilla, A., Polimeno, L., DiLeo, A., Barone, M., Ove, P., Coetzee, M., Eagon, P., Makowka, L., Ambrosino, G. and Mazzaferro, V. (1989): The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology, 9, 614-620.
10. Fujimoto, N., Igarashi, K., Kanno, J. and Inoue, T. (2004): Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J. Steroid Biochem. Mol. Biol., 91, 121-129.
11. Kolaja, K.L., Stevenson, D.E., Walborg, E.F.Jr. and Klaunig, J.E. (1996): Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis, 17, 947-954.
12. Larsen, M.C. and Jefcoate, C.R. (1995): Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism. Arch. Biochem. Biophys., 321, 467-476.
13. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. (1997): PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947.
14. Ma, W.L., Hsu, C.L., Wu, M.H., Wu, C.T., Wu, C.C., Lai, J.J., Jou, Y.S., Chen, C.W., Yeh, S. and Chang, C. (2008): Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology, 135, 947-955.
15. Mesia-Vela, S., Sanchez, R.I., Reuhl, K.R., Conney, A.H. and Kauffman, F.C. (2006): Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August- Copenhagen Irish rat. J. Pharmacol. Exp. Ther., 317, 590-597.
16. Muguruma, M., Unami, A., Kanki, M., Kuroiwa, Y, Nishimura, J., Dewa, Y., Umemura, T., Oishi, Y. and Mitsumori, K. (2007): Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats. Toxicology, 236, 61-75.
17. Mutai, M., Tatematsu, M., Aoki, T., Wada, S. and Ito, N. (1990): Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development. Cancer Lett., 49, 127-132.
18. Nagasue, N., Kohno, H., Chang, Y.C., Hayashi, T., Utsumi, Y., Nakamura, T. and Yukaya, H. (1989): Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women. Cancer, 63, 112-116.
19. Nemoto, K., Tanaka, T., Ikeda, A., Ito, S., Mizukami, M., Hikida, T., Gamou, T., Habano, W., Ozawa, S., Inoue, K., Yoshida, M., Nishikawa, A. and Degawa, M. (2011): Super-induced gene expression of the N-methyl-D-aspartate receptor 2C subunit in chemical-induced hypertrophic liver in rats. J. Toxicol., Sci., 36, 507-514.
20. Okamiya, H., Mitsumori, K., Onodera, H., Ito, S., Imazawa, T., Yasuhara, K. and Takahashi, M. (1998): Mechanistic study on liver tumor promoting effects of piperonyl butoxide in rats. Arch. Toxicol., 72, 744-750.
21. Okamura, Y., Nomoto, S., Kanda, M., Li, Q., Nishikawa, Y., Sugimoto, H., Kanazumi, N., Takeda, S. and Nakao, A. (2010): Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using doublecombination array. Cancer Lett., 289, 170-177.
22. Rao, M.S. and Reddy, J.K. (1991): An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect., 93, 205-209.
23. Rochman, H., Rosner, B., Mathey, B., Getz, G.E. and Hospelhorn, V. (1985): Age, sex and gonadal influences on oestrogen receptor content in the rat liver. J. Endocrinol., 106, 95-102.
24. Ryu, D.Y., Levi, P.E. and Hodgson, E. (1997): Regulation of hepatic CYP1A isozymes by piperonyl butoxide and acenaphthylene in the mouse. Chem. Biol. Interact., 105, 53-63.
25. Singhal, R., Shankar, K., Badger, T.M. and Ronis, M.J. (2009): Hepatic gene expression following consumption of soy protein isolate in female Sprague-Dawley rats differs from that produced by 17β-estradiol treatment. J. Endocrinol., 202, 141-152.
26. Song, C.S., Rao, T.R., Demyan, W.F., Mancini, M.A., Chatterjee, B. and Roy, A.K. (1991): Androgen receptor messenger ribonucleic acid (mRNA) in the rat liver: changes in mRNA levels during maturation, aging, and calorie restriction. Endocrinology, 128, 349-356.
27. Takahashi, O., Oishi, S., Fujitani, T., Tanaka, T. and Yoneyama, M. (1994): Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma. Fundam. Appl. Toxicol., 22, 293-303.
28. Yu, M.C. and Yuan, J.M. (2004): Environmental factors and risk for hepatocellular carcinoma. Gastroenterology, 127, S72-S78.
29. Yu, M.W., Yang, Y.C., Yang, S.Y., Cheng, S.W., Liaw, Y.F., Lin, S.M. and Chen, C.J. (2001): Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J. Natl. Cancer Inst., 93, 1644-1651.
30. Waalkes, M.P., Liu, J., Chen, H., Xie, Y., Achanzar, W.E., Zhou, Y.S., Cheng, M.L. and Diwan, B.A. (2004): Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst., 96, 466-474.